Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia

Internal Medicine

Volumn 45, Issue 5, 2006, Pages 271-273

  Higuchi, Terumi ^a   Matsukawa, Yoshihiro ^a   Okada, Kazuyoshi ^a   Oikawa, Osamu ^a   Yamazaki, Toshio ^a   Ohnishi, Yoshihiko ^a   Fujita, Takayuki ^a   Fukuda, Noboru ^a   Soma, Masayoshi ^a   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anemia; Copper deficiency; Enteral nutrition; Erythropoietin

Indexed keywords

COPPER; ENSURE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD TRANSFUSION; CASE REPORT; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DIET SUPPLEMENTATION; DRUG DOSE REDUCTION; ENTERIC FEEDING; FEMALE; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; MACROCYTIC ANEMIA; NEUTROPENIA; TREATMENT OUTCOME;

ANEMIA; CERULOPLASMIN; COPPER; COPPER SULFATE; DEFICIENCY DISEASES; ENTERAL NUTRITION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NEUTROPENIA; RENAL DIALYSIS; TREATMENT FAILURE;

EID: 33645695839     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1541     Document Type: Article

References (14)

1. Eschbach JW, Egrie JC, Dowing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial. N Engl J Med 316: 73-78, 1987.
2. Drüeke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 16: 25-28, 2001.
3. Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int 55: S107-118, 1999.
4. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175, 1993.
5. Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17: 39-43, 2002.
6. Rosenlöf K, Fyhrquist F, Tenhunen R. Erythropoietin, aluminium, and anemia in patients on hemodialysis. Lancet 335: 247-249, 1990.
7. Tarng DC, Wei TH, Huang TP, Kuo BIT, Yang WC. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 55: 2477-2486, 1999.
8. Dunlap WM, James GW 3rd, Hume DM. Anemia and neutropenia caused by copper deficiency. Ann Intern Med 80: 470-476, 1974.
9. Tainer JA, Getzoff ED, Richardson JS, Richardson DC. Structure and mechanism of copper, zinc superoxide dismutase. Nature 306: 284-287, 1983.
10. Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood 100: 1493-1495, 2002.
11. Cizewski-Culotta V, Gitlin JD. Disorders of copper metabolism. In: Metabolic Disorder and Molecular Basis of Inherited Disorders. 8th ed. Scriver CR, Beaudett AL, Sly WS, et al, Eds. McGraw-Hill, New York, 2001: 3105-3126.
12. Hirase N, Abe Y, Sadamura S, et al. Anemia and neutropenia in a case of copper deficiency: Role of copper in normal hematopoiesis. Acta Hematol 87: 195-197, 1992.
13. Tamura H, Hirose S, Watanabe O, et al. Anemia and neutropenia due to copper defficiency in enteral nutrition. JPEN J Parenter Enteral Nutr 18: 185-189, 1994.
14. Fujita M, Itakura T, Takagi Y, Okada A. Copper deficiency during total parenteral nutrition: Clinical analysis of three cases. JPEN J Parenter Enteral Nutr 13: 421-425, 1989.